68 Billon Dollar Question: Could China's Government Block Worldwide Merger Of Wyeth And Pfizer?
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Tucked away toward the end of the $68-billion merger agreement between Pfizer Inc. and Wyeth is a clause that could give the Chinese government the ultimate power to approve or block this worldwide union of American pharmaceutical giants
You may also be interested in...
China Orders Pfizer And Wyeth To Divest Certain Operations As Condition To Merger Approval
Merger watchers were keeping close tabs on whether one-year-old Anti-Monopoly Law would be used to block deal in China; divestments include an animal vaccine business.
China Orders Pfizer And Wyeth To Divest Certain Operations As Condition To Merger Approval
Merger watchers were keeping close tabs on whether one-year-old Anti-Monopoly Law would be used to block deal in China; divestments include an animal vaccine business.
China Orders Pfizer And Wyeth To Divest Certain Operations As Condition To Merger Approval
BEIJING - China's Ministry of Commerce has ordered Pfizer and Wyeth to divest themselves of certain business operations here in order to gain government approval for their $68-billion merger